ST. LOUIS (KMOX) - The U.S. Food and Drug Administration (FDA) has annouced a nationwide, voluntary recall of birth control pills by Apotex Corp.
Four lots of Drospirenone and Ethinyl Estradiol Tablets, USP may contain incorrect tablet arrangements and/or an empty blister pocket or defective blisters. As a result, users may not take a tablet due to a missing tablet or take a placebo instead of an active tablet, causing an adverse event or even pregnancy. No cases of unintended pregnancy have been reported, states to Apotex.
Patients and users are being urged to return the impacted packages to their pharmacist and direct questions about this recall to their local pharmacy and healthcare provider.
The following lots have been recalled: 7DY008A, 7DY009A, 7DY010A, and 7DY011A. The outer carton displays NDC# 60505-4183-3 and contains three inner cartons (NDC# 60505-4183-1). The expiration date is listed as 8/2020.
Drospirenone and Ethinyl Estradiol is an estrogen/progestin combination oral contraceptive indicated for the prevention of pregnancy. The tablets in the inner carton are arranged as 21 active yellow tablets followed by seven white placebo tablets.
For more information call 800-706-5575 or visit Apotex.com. Users can also read more about this recall by clicking the link here.
The affected product is manufactured by Oman Pharmaceutical Products Co. LLC.
© 2019 KMOX (Entercom). All rights reserved
